scout

Ranjana H. Advani, MD

Articles by Ranjana H. Advani, MD

ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma

ByKaren M. Winkfield, MD, PhD,Ranjana H. Advani, MD,Leslie K. Ballas, MD,Bouthaina S. Dabaja, MD,Sughosh Dhakal, MD,Christopher R. Flowers, MD, MS,Chul Soo Ha, MD,Bradford S. Hoppe, MD, MPH,David B. Mansur, MD,Nancy P. Mendenhall, MD,Monika L. Metzger, MD,John P. Plastaras, MD, PhD,Kenneth B. Roberts, MD,Ronald Shapiro, MD,Sonali M. Smith, MD,Stephanie A. Terezakis, MD,Anas Younes, MD,Louis S. Constine, MD

By combining the most recent medical literature and expert opinion, this revised guideline can aid clinicians in the complex decision-making associated with the management of recurrent Hodgkin lymphoma.

ACR Appropriateness Criteria® Localized Nodal Indolent Lymphoma

ByBradford S. Hoppe, MD, MPH,David C. Hodgson, MD,Ranjana H. Advani, MD,Bouthaina S. Dabaja, MD,Christopher R. Flowers, MD, MS,Chul Soo Ha, MD,Monika L. Metzger, MD,John P. Plastaras, MD, PhD,Kenneth B. Roberts, MD,Ronald Shapiro, MD,Stephanie A. Terezakis, MD,Karen M. Winkfield, MD, PhD,Anas Younes, MD,Louis S. Constine, MD

The present guidelines review epidemiology, pathology, presentation, workup, staging, prognostic factors, and treatment options for patients with localized nodal indolent lymphoma, with an emphasis on radiation guidelines, including radiation dose, field design, and radiation techniques.

Latest Updated Articles



Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us